Browse studies
Find your next paid study
3 recruiting studies matching your filters
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a very rare hematologic malignancy. Despite recent advances, at present there is no consensus on the op…
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Immune Oncology Research InstituteNCT05430971
Phase 1
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
The CD123-CAR T-cell therapy is a new treatment that is being investigated for treatment of AML/myelodysplastic syndrome (MDS), T- or B- acute lymphoblastic le…
AML/MDSB-ALLT-ALL+1 more
St. Jude Children's Research HospitalNCT04318678
Phase 1
A Phase I Study of Tagraxofusp With or Without Chemotherapy in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Tagraxofusp is a protein-drug conjugate consisting of a diphtheria toxin redirected to target CD123 has been approved for treatment in pediatric and adult pati…
Hematologic MalignancyAMLALL+8 more
Therapeutic Advances in Childhood Leukemia ConsortiumNCT05476770